Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Video-Assisted Thoracoscopic Surgery Versus Tube Thoracostomy with Fibrinolytics for Treatment of Empyema in
Maria Enrica Miscia1,2, Giuseppe Lauriti1,2, Dacia Di Renzo2
1Department of Medicine and Aging Science, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
Insights
Video-Assisted Thoracoscopic Surgery (VATS) significantly reduces hospital stays and improves outcomes for pediatric empyema compared to fibrinolytics. This meta-analysis confirms VATS as a superior treatment option for children with empyema.
Area of Science:
- Pediatric Thoracic Surgery
- Minimally Invasive Procedures
- Evidence-Based Medicine
Background:
- Traditional treatment for pediatric empyema involved tube thoracostomy with intra-pleural fibrinolytics, as recommended in 2005.
- Emerging evidence suggests Video-Assisted Thoracoscopic Surgery (VATS) offers superior outcomes, including reduced length of hospital stay (LOS).
- This study addresses the need for a direct comparison between VATS and fibrinolytics for pediatric empyema management.
Purpose of the Study:
- To compare the length of hospital stay (LOS) between VATS and fibrinolytics in pediatric empyema treatment.
- To evaluate secondary post-operative outcomes, including fever duration, oxygen support, chest tube removal time, and complication rates.
- To provide evidence-based recommendations for the optimal surgical approach in pediatric empyema.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, Cochrane, Web of Science, Scopus) following PRISMA guidelines.
- Randomized controlled trials (RCTs) comparing VATS and fibrinolytics for pediatric empyema were identified and analyzed.
- Meta-analysis was performed using RevMan 5.4, with data expressed as mean ± standard deviation (SD).
Main Results:
- VATS significantly reduced LOS compared to fibrinolytics (9.1 ± 1.8 vs. 11.5 ± 2.5 days, p=0.05).
- VATS was associated with shorter postoperative fever duration (4.2 ± 0.8 vs. 6.9 ± 4.6 days, p=0.007) and earlier chest tube removal (5.0 ± 2.6 vs. 9.5 ± 3.3 days, p=0.01).
- No significant differences were observed between groups for other secondary outcomes.
Conclusions:
- Video-Assisted Thoracoscopic Surgery (VATS) demonstrates superior outcomes for pediatric empyema compared to tube thoracostomy with fibrinolytics.
- VATS offers significant benefits, including shorter hospital stays and reduced fever duration.
- Further randomized controlled trials are warranted to solidify these findings and guide clinical practice.
Abstract:
Background: The British Thoracic Society recommended tube thoracostomy plus intra-pleural fibrinolytics to treat empyema in children in 2005. However, numerous comparative studies have suggested Video-Assisted Thoracoscopic Surgery (VATS) as a first line of treatment for pediatric empyema due to its superior outcomes, including shorter length of hospital stay (LOS). This meta-analysis aimed to compare the following: (1) the LOS for VATS versus fibrinolytics to treat empyema in children; (2) secondary post-operative outcomes (fever, O2 support, time taken for chest tube removal, analgesia, complications, failure, and abnormal chest X-ray at follow-up). Methods: The study was conducted according to PRISMA guidelines. A systematic search of PubMed, Cochrane, Web of Science, and Scopus was conducted according to PRISMA guidelines. Two independent investigators identified relevant studies, excluding case reports, opinion articles, and gray literature publications. A meta-analysis of randomized controlled trials (RCTs) was performed using RevMan 5.4, with data expressed as mean ± standard deviation (SD). Results: Of 1374 abstracts screened, 104 full-text articles were analyzed, and 6 RCTs (345 patients) were included in the meta-analysis. Patients undergoing VATS had significantly shorter LOS compared to those receiving fibrinolytics (9.1 ± 1.8 vs. 11.5 ± 2.5 days, p = 0.05). VATS patients also experienced shorter postoperative fever duration (4.2 ± 0.8 vs. 6.9 ± 4.6 days, p = 0.007) and earlier chest tube removal (5.0 ± 2.6 vs. 9.5 ± 3.3 days, p = 0.01). No significant differences were found between the two groups for other secondary outcomes. Conclusions: Children with empyema appear to benefit from VATS compared to tube thoracostomy plus fibrinolytics, with improved outcomes. Further RCTs are needed to corroborate these results.
More Related Videos
Related Concept Videos
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumothorax-II
Clinical Manifestations:
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...

